LOGIN
No significant difference in DVT incidence between aspirin vs rivaroxaban in total knee arthroplasty
March 2018
No significant difference in DVT incidence between aspirin vs rivaroxaban in total knee arthroplasty
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Venous thromboembolism prophylaxis after total knee arthroplasty (TKA): aspirin vs. rivaroxaban
Rev Bras Ortop. 2017 Dec 6;53(1):22-27Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
32 patients scheduled for total knee arthroplasty were randomized to thromboprophylaxis with either rivaroxaban 10mg daily or aspirin 300mg daily for 14 days after surgery. Patients were assessed for deep vein thrombosis rate, local complication rate, systemic complication rate, reoperation rate, mortality rate, postoperative blood loss, and hemoglobin and hematocrit drop. Of primary consideration...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.